These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 2847867

  • 21. Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.
    Murugavel KG, Mathews S, Jayanthi V, Shankar EM, Hari R, Surendran R, Vengatesan A, Raghuram K, Rajasambandam P, Murali A, Srinivas U, Palaniswamy KR, Pugazhendhi T, Thyagarajan SP.
    Int J Infect Dis; 2008 Nov; 12(6):e71-6. PubMed ID: 18658001
    [Abstract] [Full Text] [Related]

  • 22. HBsAg seroclearance in chronic hepatitis B in the Chinese: virological, histological, and clinical aspects.
    Yuen MF, Wong DK, Sablon E, Tse E, Ng IO, Yuan HJ, Siu CW, Sander TJ, Bourne EJ, Hall JG, Condreay LD, Lai CL.
    Hepatology; 2004 Jun; 39(6):1694-701. PubMed ID: 15185311
    [Abstract] [Full Text] [Related]

  • 23. Hepatocellular carcinoma and infections with multiple hepatitis viruses.
    Brunetto MR, Oliveri F, Colombatto P, Bonino F.
    Princess Takamatsu Symp; 1995 Jun; 25():61-6. PubMed ID: 8875610
    [Abstract] [Full Text] [Related]

  • 24. Analysis of risk factors for hepatocellular carcinoma that is negative for hepatitis B surface antigen (HBsAg).
    Shimada S, Aizawa R, Abe H, Suto S, Miyakawa Y, Aizawa Y.
    Intern Med; 2003 May; 42(5):389-93. PubMed ID: 12793707
    [Abstract] [Full Text] [Related]

  • 25. Varying nuclear staining intensity of hepatitis B virus DNA in human hepatocellular carcinoma.
    Brambilla C, Tackney C, Hirschman SZ, Colombo M, Dioguardi ML, Donato MF, Paronetto F.
    Lab Invest; 1986 Oct; 55(4):475-81. PubMed ID: 2429067
    [Abstract] [Full Text] [Related]

  • 26. Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection.
    Jang JS, Kim HS, Kim HJ, Shin WG, Kim KH, Lee JH, Kim HY, Kim DJ, Lee MS, Park CK, Jeong BH, Kim YS, Jang MK.
    J Med Virol; 2009 Sep; 81(9):1531-8. PubMed ID: 19623669
    [Abstract] [Full Text] [Related]

  • 27. Virological significance of low-level hepatitis B virus infection in patients with hepatitis C virus associated liver disease.
    Tanaka T, Inoue K, Hayashi Y, Abe A, Tsukiyama-Kohara K, Nuriya H, Aoki Y, Kawaguchi R, Kubota K, Yoshiba M, Koike M, Tanaka S, Kohara M.
    J Med Virol; 2004 Feb; 72(2):223-9. PubMed ID: 14695663
    [Abstract] [Full Text] [Related]

  • 28. Hepatitis B and C viruses in hepatitis B surface antigen negative hepatocellular carcinoma patients.
    Bréchot C, Minami M, De Mitri S, Paterlini P.
    Princess Takamatsu Symp; 1995 Feb; 25():199-209. PubMed ID: 8875625
    [Abstract] [Full Text] [Related]

  • 29. Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan?
    Shiratori Y, Shiina S, Zhang PY, Ohno E, Okudaira T, Payawal DA, Ono-Nita SK, Imamura M, Kato N, Omata M.
    Cancer; 1997 Dec 01; 80(11):2060-7. PubMed ID: 9392327
    [Abstract] [Full Text] [Related]

  • 30. Hepatitis C-related hepatocellular carcinoma. Prevalence and significance.
    Resnick RH, Koff R.
    Arch Intern Med; 1993 Jul 26; 153(14):1672-7. PubMed ID: 7687423
    [Abstract] [Full Text] [Related]

  • 31. Presence of antibodies to the hepatitis B surface antigen is associated with an excess risk for hepatocellular carcinoma among non-Asians in Los Angeles County, California.
    Yu MC, Yuan JM, Ross RK, Govindarajan S.
    Hepatology; 1997 Jan 26; 25(1):226-8. PubMed ID: 8985295
    [Abstract] [Full Text] [Related]

  • 32. Selective accumulation of the X transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma.
    Paterlini P, Poussin K, Kew M, Franco D, Brechot C.
    Hepatology; 1995 Feb 26; 21(2):313-21. PubMed ID: 7843699
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Alcoholic liver diseases in Japan and modification by hepatitis virus].
    Horie Y, Yamagishi Y, Ishii H.
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2003 Oct 26; 38(5):403-14. PubMed ID: 14639919
    [Abstract] [Full Text] [Related]

  • 35. High prevalence of hepatitis B virus infection and inferior vena cava obstruction among patients with liver cirrhosis or hepatocellular carcinoma in Nepal.
    Shrestha SM, Shrestha S, Shrestha A, Tsuda F, Endo K, Takahashi M, Okamoto H.
    J Gastroenterol Hepatol; 2007 Nov 26; 22(11):1921-8. PubMed ID: 17914971
    [Abstract] [Full Text] [Related]

  • 36. SEN virus infection in patients with hepatocellular carcinoma.
    Momosaki S, Umemura T, Scudamore CH, Kojiro M, Alter HJ, Tabor E.
    J Viral Hepat; 2005 Jul 26; 12(4):435-8. PubMed ID: 15985016
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.